Physician profile
Amy Eagan
NPI 1326365313
$558.78
in general payments reported to CMS, 2019-2025
13 companies · $145 in 2025
The $145 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.83 · 2022: $37.18 · 2023: $63.93 · 2024: $271 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $124.99 | 2024 | Dupixent |
| Corium, LLC | $111.56 | 2024-2025 | Azstarys |
| Glaxosmithkline, LLC. | $74.22 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Pfizer INC. | $51.64 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.95 | 2025 | Elaprase |
| Sanofi-Aventis U.S. LLC | $36.53 | 2024 | |
| Sanofi Pasteur INC. | $32.35 | 2023-2024 | |
| Verrica Pharmaceuticals INC. | $17.73 | 2024 | Ycanth |
| Cranial Technologies, INC | $14.98 | 2024 | Doc Band |
| Medline Industries Lp | $14.70 | 2023 | |
| Cipher Pharmaceuticals US LLC | $14.08 | 2025 | Spinosad, Natroba |
| Collegium Pharmaceutical, INC. | $14.05 | 2025 | Jornay Pm |
| Shire North American Group INC | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Eagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.